Nagrao MV, Skoulidis F, Montesion M, Schulze K, Bara I, Shen V, HuS, Elamin YY, Le X, Goldberg ME, Wu CJ, Zhang J, Barreto DS, Rinsurongkawong W, Simon G, Roth J, Swisher SG , Lee JJ, Tsao A, Papadimitrakopoulou V Gibbons DL, Glisson BS, Va M, Alexander BM, Frampton GM, Albacker LA, Shames DS, Zhang J, Heymach JV
A note on honesty: an ingredient having strong published evidence in one form does not mean every formulation or delivery method carries that same evidence
Lot Traceability and Public COA Library Every vial carries a lot identifier printed on the label that ties to one complete analytical record - HPLC, LC-MS, and endotoxin
Follow-up visit : During the IV/IM therapy plan, a follow-up visit is arranged with the healthcare Prescriber to assess progress on the treatment/ therapy plan, make any necessary adjustments if necessary, and provide ongoing support and guidance
The plaintiffs statement outlines the framework they will argue and attempts to dismiss the defendants arguments from their filing